IOVA
Iovance Biotherapeutics Inc
11.00$
+1.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | – | 8,880.3% | 904.5% | 75.6% | 2.8% | |
| – | – | – | – | – | – | – | – | -8,880.3% | -804.5% | 24.4% | 97.2% | |
| – | – | – | – | – | – | – | – | 123,857.6% | 28,938.4% | 172.1% | 114.0% | |
| – | – | – | – | – | – | – | – | 43,738.2% | 2,329.6% | 31.6% | 57.8% | |
| – | – | – | – | – | – | – | – | 167,595.8% | 37,930.4% | 265.3% | 250.3% | |
| – | – | – | – | – | – | – | – | -167,595.8% | -38,735.0% | -240.9% | -153.1% | |
| – | – | – | – | – | – | – | – | 1,254.2% | – | – | – | |
| – | – | – | – | – | – | – | – | -166,341.6% | -37,638.0% | -228.6% | -149.2% | |
| – | – | – | – | – | – | – | – | -2,508.4% | -292.6% | -1.7% | -0.8% | |
| – | – | – | – | – | – | – | – | -163,833.2% | -37,345.4% | -226.8% | -148.4% | |
| – | – | – | – | – | – | – | – | -158,715.5% | -34,851.9% | -202.0% | -135.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.